Previous clinical studies have preliminarily identified neuron-specific enolase (NSE), fibrinogen (FIB), and gastrin-releasing peptide precursor as key protein molecules that influence the treatment efficacy and prognosis of small cell lung cancer (SCLC) patients. The gene discussed is ENO2; the disease is small cell lung carcinoma.